You are here

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

Last updated on February 21, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Glendale, California, 91206 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer's Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
55-85 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects must have Alzheimer's dementia with a Mini Mental State Examination score
between 18-26, inclusive.

- Subjects must have a reliable caregiver.

- Subjects must be on Aricept

- Memantine is allowed if subjects are on a stable dose

- Subjects must be in reasonably good health, based on medical history, physical
examination, vital signs, and ECG, with no serious or unstable disease within the past
3 months.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects with clinically significant heart disease cannot participate.

- Subjects with a past or current history of seizures cannot participate.

NCT00988598
Pfizer
Completed
A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Alzheimer's Disease
NCT00945672
All Genders
50+
Years
Multiple Sites
Alzheimer's Disease
NCT01227564
All Genders
50+
Years
Multiple Sites
Alzheimer's Disease, Huntington's Disease
NCT00825084
All Genders
18+
Years
Glendale, California
Alzheimer's Disease
NCT00843115
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now